Featured
Breakthrough Bispecific Antibody 10E8.4/iMab Shows Promise in First-in-Human HIV-1 Phase 1 Trial
In a landmark therapeutic advancement, researchers have disseminated the results of a first-in-human phase 1 trial for a novel bispecific antibody, 10...
Read Full Story →